Comprehensive Tumor
DNA and RNA Sequencing
Circulogene’s comprehensive tumor DNA and RNA sequencing is the only plasma testing available that combines the most advanced next-generation sequencing (NGS) and polymerase chain reaction (PCR) technology to detect and monitor cfDNA and cfRNA within well-characterized, well-documented, actionable cancer-associated genes.
50,000+
50,000 cancer patients have benefited from our innovative, best-in-class liquid biopsy. Our novel approach has created unique liquid biopsy tests that aid oncologists in personalizing and monitoring the patient’s treatment plan with the goal of better outcomes and survival.
Each patient’s cancer is unique, and understanding the origins and severity of the cancer aids oncologists to personalize the patient’s treatment plan at the time of diagnosis and throughout their cancer journey.
BLOG
Latest News
From Circulogene
Circulogene Announces Exclusive Commercial Launch of LungLifeAI® for Indeterminate Pulmonary Nodule Assessment
Circulogene is excited to announce the exclusive commercial launch of LungLifeAI®
Six Molecular Diagnostic Companies To Watch- Circulogene featured on Labiotech.eu
Labiotech.eu was founded in 2014 by two biotech engineers in response to the lack of digital media covering the European biotechnology industry.
